Medicare Enrolled
Dr. Mary Crow, M.D.
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Crow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crow?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Crow
Dr. Mary Crow is a hematology & oncology specialist in Kingwood, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Crow performed 64,335 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Crow received a total of $24,954 from 99 pharmaceutical and/or device companies across 1181 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Crow is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 14% volume in TX
$24,954 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗64,335
Medicare services
Top 14% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
40,500 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,650 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $55 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,400 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,481 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 960 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
540 | $23 | $82 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
522 | $127 | $481 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
392 | $89 | $347 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
389 | $19 | $61 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
325 | $11 | $38 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
237 | $101 | $375 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
166 | $7 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
146 | $22 | $80 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
139 | $51 | $183 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
123 | $46 | $178 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
90 | $1 | $3 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
59 | $18 | $73 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $63 | $246 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 39 | $110 | $295 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
38 | $1,169 | $5,567 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
34 | $58 | $437 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
30 | $58 | $328 |
| New patient office visit, complex (60-74 min) | 24 | $165 | $580 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
21 | $155 | $812 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
16 | $55 | $187 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $17 | $61 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $99 | $443 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
64.6% high complexity
33.1% medium
2.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,954
Total received (2018-2024)
Avg $3,565/year across 7 years
Top 18% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,181
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$277
2023
$3,994
2022
$3,107
2021
$3,748
2020
$3,234
2019
$5,873
2018
$4,722
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$116
AstraZeneca Pharmaceuticals LP
$34
ABBVIE INC.
$30
Janssen Biotech, Inc.
$24
SpringWorks Therapeutics, Inc.
$20
PFIZER INC.
$20
Incyte Corporation
$17
Boston Scientific Corporation
$16
Top 3 companies account for 64.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,775
Novartis Pharmaceuticals Corporation
$1,679
Merck Sharp & Dohme Corporation
$1,441
Amgen Inc.
$1,405
R-Pharm US LLC
$1,306
E.R. Squibb & Sons, L.L.C.
$1,212
PFIZER INC.
$1,044
Astellas Pharma US Inc
$799
AstraZeneca Pharmaceuticals LP
$795
Pharmacyclics LLC, An AbbVie Company
$777
Seagen Inc.
$694
GlaxoSmithKline, LLC.
$622
Eisai Inc.
$584
GENZYME CORPORATION
$535
Lilly USA, LLC
$522
Takeda Pharmaceuticals U.S.A., Inc.
$515
Celgene Corporation
$437
Genentech USA, Inc.
$436
Daiichi Sankyo Inc.
$378
Kite Pharma, Inc.
$344
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
Incyte Corporation
$322
EISAI INC.
$319
Alexion Pharmaceuticals, Inc.
$296
Karyopharm Therapeutics Inc.
$286
Ipsen Biopharmaceuticals, Inc
$242
AVEO Pharmaceuticals, Inc.
$227
AbbVie Inc.
$219
MorphoSys, US Inc.
$211
Merck Sharp & Dohme LLC
$203
Pharmacyclics LLC, an AbbVie Company
$196
Gilead Sciences, Inc.
$189
Teva Pharmaceuticals USA, Inc.
$173
Dendreon Pharmaceuticals LLC
$159
Bayer HealthCare Pharmaceuticals Inc.
$158
Puma Biotechnology, Inc.
$150
BeiGene USA, Inc.
$145
Stemline Therapeutics Inc.
$135
Exelixis Inc.
$127
Regeneron Healthcare Solutions, Inc.
$110
TESARO, Inc.
$101
Janssen Pharmaceuticals, Inc
$100
ABBVIE INC.
$93
Foundation Medicine, Inc.
$92
Rigel Pharmaceuticals, Inc.
$90
TAIHO ONCOLOGY, INC.
$88
Agios Pharmaceuticals, Inc.
$87
SOBI, INC
$87
Taiho Oncology, Inc.
$84
CTI BioPharma Corp.
$81
SERVIER PHARMACEUTICALS LLC
$69
JAZZ PHARMACEUTICALS INC.
$69
Myovant Sciences Inc.
$68
Dova Pharmaceuticals
$63
Kyowa Kirin, Inc.
$61
TOLMAR Pharmaceuticals, Inc.
$60
Coherus Biosciences Inc.
$56
Genmab U.S., Inc.
$54
Spectrum Pharmaceuticals Inc.
$51
Adaptive Biotechnologies Corporation
$44
Acrotech Biopharma LLC
$44
ARRAY BIOPHARMA INC
$43
Secura Bio, Inc.
$43
G1 Therapeutics, Inc.
$42
Deciphera Pharmaceuticals Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$39
Pharming Healthcare, Inc.
$39
Acceleron Pharma, Inc.
$37
Lexicon Pharmaceuticals, Inc.
$36
AMAG Pharmaceuticals, Inc.
$33
Mirati Therapeutics, Inc.
$32
Seattle Genetics, Inc.
$30
TerSera Therapeutics LLC
$29
Sumitomo Pharma America, Inc.
$27
Mylan Institutional Inc.
$27
Emmaus Medical, Inc.
$24
NOVARTIS PHARMACEUTICALS CORPORATION
$24
Blueprint Medicines Corporation
$23
MACROGENICS, INC.
$22
Abbott Laboratories
$21
MEDIVATION FIELD SOLUTIONS LLC
$21
SpringWorks Therapeutics, Inc.
$20
Sandoz Inc.
$20
EUSA Pharma (US) LLC
$19
Sirtex Medical Inc
$19
Clovis Oncology, Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$17
Nestle HealthCare Nutrition Inc.
$17
Jazz Pharmaceuticals Inc.
$16
Boston Scientific Corporation
$16
ADC Therapeutics America, Inc.
$16
Advanced Accelerator Applications
$15
Global Blood Therapeutics, Inc.
$15
Pharmacosmos Therapeutics Inc.
$15
Tactile Systems Technology Inc
$15
Array BioPharma Inc.
$14
Allergan Inc.
$14
Blue Earth Diagnostics Limited
$12
Heron Therapeutics, Inc.
$6
Top 3 companies account for 23.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYSTOLIC · Balversa · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARDIOMEMS · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DALVANCE · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Endari · Enhertu · Erivedge · Erleada · FARYDAK · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · Farydak · Folotyn · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUX-Dx Insertable Cardiac Monitor · LYNPARZA · Lenvima · Lonsurf · Lutathera · MARGENZA · MEKINIST · MK-7339 · MONJUVI · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RUCONEST · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEFLARO · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYNDAQEL · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
41
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Crow is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Crow experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Crow performed 40,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Crow receive payments from pharmaceutical companies?
Yes. Dr. Crow received a total of $24,954 from 99 companies across 1,181 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crow's costs compare to other hematology & oncology specialists in Kingwood?
Dr. Crow's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kingwood
Browse hematology & oncology specialists in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology